Skip to main content

Table 3 Secondary outcomes: follow-ups between months 1 and 13

From: INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact)

 

Telemetry

(N = 102)

n (%) / mean ± SD

Personal contact

p-value (telemetry vs. personal contact)

p-value (telemetry vs. remote+phone vs. visit)

All

(N = 108)

n (%) / mean ± SD

Remote+phone

(N = 53)

n (%) / mean ± SD

Visit

(N = 55)

n (%) / mean ± SD

FU duration (days)

372.8 ± 100.3

366.9 ± 127.5

349.9 ± 147.8

384.0 ± 102.0

0.689

0.490

Unscheduled FUs

 No. of FUs /patient

1.2 ± 2.6

0.9 ± 1.8

1.0 ± 1.7

0.8 ± 2.0

0.550

0.285

 Total number

120

99

54

45

  

 Considered reasonable

90 (75.0)

77 (77.8%)

43 (79.6)

34 (75.6)

0.631

0.797

 With findings

55 (45.8)

57 (57.6)

28 (51.9)

29 (64.4)

0.084

0.104

 Medical

40 (33.3)

37 (37.4)

17 (31.5)

20 (44.4)

0.534

0.335

 Technical

9 (7.5)

12 (12.1)

9 (16.7)

3 (6.7)

0.249

0.126

All FUs

 Patients with relevant findings at ≥1 FU

50 (49.0)

50 (46.3)

26 (49.1)

24 (43.6)

0.693

0.789

 Medical

42 (41.2)

40 (37.0)

19 (35.8)

21 (38.2)

0.539

0.803

 Technical

16 (15.7)

19 (17.6)

11 (20.8)

8 (14.5)

0.711

0.642

 Patients with ICD therapy at ≥1 FU

17 (16.7)

15 (13.9)

7 (13.2)

8 (14.5)

0.576

0.839

 ICD shock

9 (8.8)

9 (8.3)

4 (7.5)

5 (9.1)

0.899

0.792

 ATP therapy

16 (15.7)

14 (13.0)

7 (13.2)

7 (12.7)

0.573

0.851

System revisions

 Patients requiring ≥1

6 (5.9)

1 (0.9)

1 (1.9)

0 (0)

0.059

0.141

 Mean per patient

0.06 ± 0.02

0.01 ± 0.10

0.02 ± 0.14

0.00 ± 0.00

0.046

0.118

  1. FU follow-up, ICD implanted cardioverter-defibrillator, ATP anti-tachycardia pacing